Mary J. Mullany is a partner in the Business and Finance Department and Practice Leader of the Securities Group. She is also a member of the Mergers and Acquisitions/Private Equity, Employee Benefits and Executive Compensation, Life Sciences/Technology, Health Care, and Insurance Groups, as well as the Health Care Reform Initiative.
Ms. Mullany concentrates her practice in the areas of securities, mergers and acquisitions, corporate financing (public and private), executive compensation, corporate governance, pharmaceutical and life sciences licensing and collaborations, general corporate law, business counseling, and health care law. Her client base includes public and private regionally based companies in a variety of industries, including life science, technology, medical device, health care, and insurance.
Ms. Mullany has worked most recently on executive compensation and corporate governance matters and merger and acquisition transactions in the life science industry. She counsels public and private companies in the areas of corporate governance, disclosure obligations, executive compensation, and financing alternatives. Much of Ms. Mullany's work with pharmaceutical, biotechnology, and life science companies focuses on mergers and acquisitions, securities offerings, and other corporate financing, and on licensing agreements, including collaborations and joint ventures.
Before becoming an attorney, Ms. Mullany was a registered nurse with experience in critical care and risk management.
Pro Bono Experience
Ms. Mullany works with pro bono corporate clients in the areas of contracting and corporate governance requirements.